Obstetrics & Gynecology, Obstetrics · Midland, TX
NPI
1205034766
Since 2007
Specialty
Obstetrics & Gynecology, Obstetrics
Code 207VX0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2500 W Illinois Ave, Suite 100
Midland, TX, 79701
Phone (432) 699-2370
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
4,494 services
Medicare patients, 2024
218
Average age 70
Drug cost, 2024
$48K
967 prescriptions
Company payments, 2025
$125
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Reagan D Viney was code J0897 (injection, denosumab, 1 mg), 2,040 times for 19 patients. In total Reagan D Viney billed 4,494 services in 49 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,040 | 19 | $18.87 | $39K |
| 99213 Office E&M - Established | Office | 146 | 122 | $55.15 | $8,052 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 111 | 111 | $37.26 | $4,136 |
| 77067 Mammography | Office | 89 | 89 | $114.64 | $10K |
| 77063 Mammography | Office | 86 | 86 | $49.29 | $4,239 |
| 80076 Clinical Chemistry | Office | 57 | 55 | $8.01 | $457 |
| 80048 Clinical Chemistry | Office | 57 | 57 | $8.29 | $473 |
| 84481 Clinical Chemistry | Office | 56 | 54 | $16.51 | $925 |
| 84443 Clinical Chemistry | Office | 53 | 51 | $16.46 | $872 |
| 84439 Clinical Chemistry | Office | 53 | 51 | $8.84 | $469 |
| 85025 Blood Count | Office | 52 | 52 | $7.61 | $396 |
| 83036 Blood Count | Office | 51 | 51 | $9.52 | $486 |
| 80061 Clinical Chemistry | Office | 47 | 47 | $13.12 | $617 |
| 96372 Injection Administration | Office | 46 | 20 | $8.60 | $396 |
| 81001 Clinical Chemistry | Office | 38 | 34 | $3.11 | $118 |
By year: 2022 $44K for 2,615 services; 2023 $68K for 3,483 services; 2024 $90K for 4,494 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80076 Clinical Chemistry | 57 | 55 | $8.01 | $457 |
| 80048 Clinical Chemistry | 57 | 57 | $8.29 | $473 |
| 84481 Clinical Chemistry | 56 | 54 | $16.51 | $925 |
| 84443 Clinical Chemistry | 53 | 51 | $16.46 | $872 |
| 84439 Clinical Chemistry | 53 | 51 | $8.84 | $469 |
| 85025 Blood Count | 52 | 52 | $7.61 | $396 |
| 83036 Blood Count | 51 | 51 | $9.52 | $486 |
| 80061 Clinical Chemistry | 47 | 47 | $13.12 | $617 |
| 81001 Clinical Chemistry | 38 | 34 | $3.11 | $118 |
| 81003 Clinical Chemistry | 25 | 25 | $2.20 | $55 |
Medicare prescription drug claims, 2024
In 2024, the drug Reagan D Viney prescribed most often to Medicare patients was Estradiol, with 145 prescriptions and refills. In total Reagan D Viney wrote 967 Medicare prescriptions that cost $48K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 145 | 367 | 66 | $9,638 |
| Levothyroxine Sodium Generic | 99 | 264 | 30 | $1,255 |
| Rosuvastatin Calcium Generic | 54 | 152 | 17 | $265 |
| Ibandronate Sodium Generic | 43 | 116 | 16 | $1,125 |
| Citalopram Hbr Citalopram Hydrobromide | 41 | 107 | 11 | $230 |
| Synthroid Levothyroxine Sodium | 40 | 105 | 11 | $1,708 |
| Zolpidem Tartrate Generic | 38 | 38 | Under 11 | $274 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 35 | 35 | 16 | $322 |
| Hydrochlorothiazide Generic | 24 | 72 | Under 11 | $42.75 |
| Atorvastatin Calcium Generic | 23 | 61 | Under 11 | $149 |
| Alendronate Sodium Generic | 21 | 43 | Under 11 | $173 |
| Premarin Estrogens, Conjugated | 18 | 50 | Under 11 | $8,886 |
| Fluconazole Generic | 17 | 17 | 15 | $41.31 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 16 | 46 | Under 11 | $274 |
| Raloxifene Hcl Generic | 16 | 48 | Under 11 | $1,173 |
Brand drugs: - claims; generic drugs: 860 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Reagan D Viney $125 ($125 in general payments such as food, travel and fees) from 6 companies. The largest payer was Sumitomo Pharma America, Inc. with $42.94.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.